Biotest Aktiengesellschaft (BIO3) — Defensive Interval Ratio

Latest as of March 2025: 395 days

Biotest Aktiengesellschaft (BIO3) has a Defensive Interval Ratio of 395 days as of March 2025. Defensive assets of €173.20 Million (cash €-, short-term investments €18.00 Million, receivables €155.20 Million) cover 395 days of daily cash needs of €438.63K/day. Check how tangible is Biotest Aktiengesellschaft's equity to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

395 days
Days of operational coverage

Defensive Assets

€173.20 Million
Cash + ST Investments + Receivables

Daily Cash Need

€438.63K
Current Liabilities ÷ 365

Current Liabilities

€160.10 Million
EUR

Biotest Aktiengesellschaft Defensive Interval Ratio (2008–2024)

This chart shows how Biotest Aktiengesellschaft's Defensive Interval Ratio has evolved across 17 annual periods from 2008 to 2024. As of March 2025, the ratio stands at 395 days, meaning defensive assets of €173.20 Million can fund 395 days of operations without new revenue. Also explore Biotest Aktiengesellschaft (BIO3) equity growth momentum to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for Biotest Aktiengesellschaft (2008–2024)

The table below presents the year-by-year Defensive Interval Ratio for Biotest Aktiengesellschaft from 2008 to 2024, covering 17 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see BIO3 stock market capitalisation.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2024 487 days €213.60 Million €438.63K/day €- €11.70 Million ▲ +281 days
2023 206 days €217.20 Million €1.06 Million/day €- €10.40 Million ▼ -355 days
2022 560 days €199.90 Million €356.71K/day €- €20.00 Million ▼ -36 days
2021 597 days €173.90 Million €291.51K/day €- €13.10 Million ▼ -85 days
2020 681 days €197.10 Million €289.32K/day €- €17.90 Million ▲ +72 days
2019 609 days €192.00 Million €315.07K/day €- €24.90 Million ▼ -91 days
2018 700 days €240.90 Million €344.11K/day €- €44.20 Million ▲ +497 days
2017 203 days €139.70 Million €688.22K/day €- €5.90 Million ▼ -234 days
2016 437 days €174.70 Million €400.00K/day €- €10.00 Million ▼ -395 days
2015 832 days €286.70 Million €344.66K/day €- €99.90 Million ▲ +145 days
2014 687 days €242.70 Million €353.15K/day €- €54.70 Million ▲ +327 days
2013 360 days €122.70 Million €340.55K/day €- €- ▲ +143 days
2012 217 days €98.13 Million €451.72K/day €- €-72.00K ▼ -104 days
2011 321 days €129.88 Million €404.75K/day €- €- ▲ +23 days
2010 298 days €107.24 Million €359.86K/day €- €- ▲ +20 days
2009 278 days €113.30 Million €407.61K/day €- €- ▲ +270 days
2008 8 days €2.44 Million €324.23K/day €- €- —
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)